Research

Life Sciences & Biotechnology

Title :

studying the role of lipin1-Akt interaction on the regulation of PI3K-Akt-mTOR pathway and investigating their effect on tumorigenesis

Area of research :

Life Sciences & Biotechnology

Focus area :

Oncology

Principal Investigator :

Dr. Misbah Un Nisa, ICMR- National Institute for Research in Reproductive and Child Health, Mumbai, Maharashtra

Timeline Start Year :

2024

Timeline End Year :

2026

Contact info :

Details

Executive Summary :

Lipin-1 is a crucial protein that plays a crucial role in maintaining cellular metabolic homeostasis and controlling cellular growth and proliferation. Its dysregulation has been linked to the onset and development of cancer, with its expression levels correlated with tumor aggressivity and poor prognosis. The pathways determining lipin-1's role in cancer are complex and multifactorial. studies have shown that lipin-1 has a role in cell cycle progression, and its inhibition or knockdown causes spindle abnormalities. Additionally, lipin-1 modulates the Akt1 signaling pathway, a cellular serine or threonine protein kinase involved in cell cycle regulation and key cellular functions. Akt1 has been implicated in cancer development and progression, and targeting it has emerged as a promising approach for cancer therapy. Lipin-1 is a downstream target of the PI3K-Akt-mTOR pathway and a bona fide target of mTORC1 kinase that phosphorylates it. The study aims to understand the precise mechanism behind the relationship between lipin-1 and Akt1 or mTORC2 and study its significance in mammalian cells, particularly in cancers. Lipin-1 is an intriguing protein that needs further investigation in cancers and metabolic disorders due to its known role in lipid metabolism regulation and the proposed mechanism of lipin-1 in cell cycle progression and PI3K-Akt-mTOR signaling.

Total Budget (INR):

Organizations involved